RxDoctor Payments Data

Luke Maxfield, DO

Dermatology · Clinton, NCNPI 1144681255

Payments from drug & device makers

$23,279in general payments, 2019–2025

Across 157 payments — averaging $148.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$11K
  • Galderma Laboratories, L.p.$10K
  • Sun Pharmaceutical Industries Inc.$721
  • Incyte Corporation$290
  • Lilly USA, LLC$217
  • Regeneron Healthcare Solutions, Inc.$149
  • plus $1K from 21 others
$1,200in research payments, 2019–2025

Across 1 payment — averaging $1200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1K

What the payments were for

  • Consulting fees$9,62541%
  • Speaking & faculty fees$10,00043%
  • Food & beverage$3,43515%
  • Education$2201%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,279 in reported general payments places this provider in the 85th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$257,386
Medicare patients
820
Services billed
2,683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$330,447
Dupixent PenDupilumab42$174,173
Fluorouracil68$4,469
Tacrolimus41$4,063
Clobetasol Propionate70$3,562
Timolol Maleate23$3,004
Ketoconazole152$2,049
Metronidazole23$1,383
Fluocinolone Acetonide32$1,237
Ciclopirox36$1,051
Doxycycline Hyclate131$950
Clindamycin Phosphate16$865
Doxycycline Monohydrate37$433
Triamcinolone Acetonide44$414
CiclopiroxCiclopirox Olamine12$233

Paid to pharmacies, not to this prescriber.

Other dermatology in Clinton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →